| Dr James Paul Tompkins, MD | |
|
601 W Main St, Byrdstown, TN 38549-2400 | |
| (931) 864-3232 | |
| (931) 864-3230 |
| Full Name | Dr James Paul Tompkins |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 601 W Main St, Byrdstown, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508057159 | NPI | - | NPPES |
| 3001434 | Medicaid | TN | |
| 6064424 | Other | TN | BCBS |
| 7100032150 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 43198 (Tennessee) | Secondary |
| 208M00000X | Hospitalist | 43198 (Tennessee) | Secondary |
| 207Q00000X | Family Medicine | 43198 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Quality Home Health | Jamestown, TN | Home health agency |
| Amedisys Home Health | Livingston, TN | Home health agency |
| Caris Healthcare | Murfreesboro, TN | Hospice |
| Livingston Regional Hospital | Livingston, TN | Hospital |
| Cookeville Regional Medical Center | Cookeville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Firstchoice Family Care | 2668802968 | 2 |
News Archive
Seven new Prosperity Partnerships projects that will build links between the UK's research base and leading industry partners such as AkzoNobel , AstraZeneca, Google, Rolls-Royce, Tata Steel, and Weir Group, plus small-to-medium enterprise, Oxford PV will be unveiled today by the Engineering and Physical Sciences Research Council (EPSRC) at Prince Philip House, Carlton Terrace, London.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."
A better understanding of the stomach's immune response to Helicobater pylori (H. pylori) infection could lead to new therapies targeting damage in the stomach, report researchers in the March issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
› Verified 1 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050207000666 |
News Archive
Seven new Prosperity Partnerships projects that will build links between the UK's research base and leading industry partners such as AkzoNobel , AstraZeneca, Google, Rolls-Royce, Tata Steel, and Weir Group, plus small-to-medium enterprise, Oxford PV will be unveiled today by the Engineering and Physical Sciences Research Council (EPSRC) at Prince Philip House, Carlton Terrace, London.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."
A better understanding of the stomach's immune response to Helicobater pylori (H. pylori) infection could lead to new therapies targeting damage in the stomach, report researchers in the March issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
› Verified 1 days ago
| Entity Name | App Of Tennessee Hm, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396160768 PECOS PAC ID: 5395960694 Enrollment ID: O20140630001088 |
News Archive
Seven new Prosperity Partnerships projects that will build links between the UK's research base and leading industry partners such as AkzoNobel , AstraZeneca, Google, Rolls-Royce, Tata Steel, and Weir Group, plus small-to-medium enterprise, Oxford PV will be unveiled today by the Engineering and Physical Sciences Research Council (EPSRC) at Prince Philip House, Carlton Terrace, London.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."
A better understanding of the stomach's immune response to Helicobater pylori (H. pylori) infection could lead to new therapies targeting damage in the stomach, report researchers in the March issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
› Verified 1 days ago
| Entity Name | Firstchoice Family Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962961466 PECOS PAC ID: 2668802968 Enrollment ID: O20200429002378 |
News Archive
Seven new Prosperity Partnerships projects that will build links between the UK's research base and leading industry partners such as AkzoNobel , AstraZeneca, Google, Rolls-Royce, Tata Steel, and Weir Group, plus small-to-medium enterprise, Oxford PV will be unveiled today by the Engineering and Physical Sciences Research Council (EPSRC) at Prince Philip House, Carlton Terrace, London.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."
A better understanding of the stomach's immune response to Helicobater pylori (H. pylori) infection could lead to new therapies targeting damage in the stomach, report researchers in the March issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
› Verified 1 days ago
| Entity Name | Cookeville Hospitalist Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467133371 PECOS PAC ID: 1254794282 Enrollment ID: O20230824000235 |
News Archive
Seven new Prosperity Partnerships projects that will build links between the UK's research base and leading industry partners such as AkzoNobel , AstraZeneca, Google, Rolls-Royce, Tata Steel, and Weir Group, plus small-to-medium enterprise, Oxford PV will be unveiled today by the Engineering and Physical Sciences Research Council (EPSRC) at Prince Philip House, Carlton Terrace, London.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."
A better understanding of the stomach's immune response to Helicobater pylori (H. pylori) infection could lead to new therapies targeting damage in the stomach, report researchers in the March issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Paul Tompkins, MD 557 Means Rd, Byrdstown, TN 38549-4601 Ph: () - | Dr James Paul Tompkins, MD 601 W Main St, Byrdstown, TN 38549-2400 Ph: (931) 864-3232 |
News Archive
Seven new Prosperity Partnerships projects that will build links between the UK's research base and leading industry partners such as AkzoNobel , AstraZeneca, Google, Rolls-Royce, Tata Steel, and Weir Group, plus small-to-medium enterprise, Oxford PV will be unveiled today by the Engineering and Physical Sciences Research Council (EPSRC) at Prince Philip House, Carlton Terrace, London.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."
A better understanding of the stomach's immune response to Helicobater pylori (H. pylori) infection could lead to new therapies targeting damage in the stomach, report researchers in the March issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.
› Verified 1 days ago
Dr. Cynthia Karabeth Cahill, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 8401 Hwy 111, Byrdstown, TN 38549 Phone: 931-864-3187 | |
Mr. Larry Michael Mason, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8401 Highway 111, Byrdstown, TN 38549 Phone: 931-864-3187 Fax: 931-864-7102 |